Risk factors for Hodgkin's disease by Epstein-Barr virus (EBV) status: Prior infection by EBV and other agents

被引：95

作者：

Alexander F.E. ^{[1
]}

Jarrett R.F. ^{[2
]}

Lawrence D. ^{[3
]}

Armstrong A.A. ^{[2
]}

Freeland J. ^{[2
]}

Gokhale D.A. ^{[4
]}

Kane E. ^{[5
]}

Taylor G.M. ^{[4
]}

Wright D.H. ^{[6
]}

Cartwright R.A. ^{[5
]}

机构：

[1] Department of Public Health Science, University of Edinburgh, Medical School, Edinburgh EH8 9AG, Teviot Place

[2] Leukaemia Res. Fund Virus Centre, Department of Veterinary Pathology, Glasgow G61 1QH, Bearsden Road

[3] Clinical Trial and Statistics Unit, Institute of Cancer Research, Sutton, Surrey SM2 5NG, Block D

[4] N. West Immunogenetics Laboratory, St. Mary's Hospital, Manchester M13 0JH, Hathersage Road

[5] Leukaemia Research Fund, Centre for Clinical Epidemiology, UMV Leeds, Leeds LS2 9NG

[6] Department of Pathology, University of Southampton, Southampton General Hospital, Southampton, South Block

来源：

British Journal of Cancer | 2000年 / 82卷 / 5期

关键词：

Aetiology; Epstein-Barr virus; Hodgkin's disease; Infectious agents; Late host exposure model;

D O I：

10.1054/bjoc.1999.1049

中图分类号：

学科分类号：

摘要：

A UK population-based case-control study of Hodgkin's disease (HD) in young adults (16-24 years) included 118 cases and 237 controls matched on year of birth, gender and county of residence. The majority (103) of the cases were classified by Epstein-Barr virus (EBV) status (EBV present in Reed-Stenberg cells), with 19 being EBV-positive. Analyses using conditional logistic regression are presented of subject reports of prior infectious disease (infectious mononucleosis (IM), chicken pox, measles, mumps, pertussis and rubella). In these analyses HD cases are compared with matched controls, EBV-positive cases and EBV-negative cases are compared separately with their controls and formal tests of differences of association by EBV status are applied. A prior history of IM was positively associated with HD (odds ratio (OR) = 2.43, 95% confidence interval (CI) = 1.10-5.33) and with EBV-positive HD (OR = 9.16, 95% CI = 1.07-78.31) and the difference between EBV-positive and EBV-negative HD was statistically significant (P = 0.013). The remaining infectious illnesses (combined) were negatively associated with HD, EBV-positive HD and EBV-negative HD (in the total series, for ≥ 2 episodes compared with ≤ 1, OR = 0.45, 95% CI = 0.25-0.83). These results support previous evidence that early exposure to infection protects against HD and that IM increases subsequent risk; the comparisons of EBV-positive and EBV-negative HD are new and generate hypotheses for further study. (C) 2000 Cancer Research Campaign.

引用

页码：1117 / 1121

页数：4

共 23 条

[11] Levine R., Zhu K.M., Gu Y., Brann E., Hall I., Caplan L., Baum M., Self-reported infectious mononucleosis and 6 cancers. A population based case-control study, Scand J Inf Dis, 30, pp. 211-214, (1998)
[12] Mack T.M., Cozen W., Shibata D.K., Weiss L.M., Nathwani B.N., Hernandez A.M., Taylor C.R., Hamilton A.S., Deapen D.M., Rappaport E.B., Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young adult form of the disease, N Engl J Med, 332, pp. 413-418, (1995)
[13] MacMahon M., Epidemiology of Hodgkin's disease, Cancer Res, 26, (1966)
[14] Miller R.W., Beebe G.W., Infectious mononucleosis and the empirical risk of cancer, J Natl Cancer Inst, 50, (1973)
[15] Michels K.B., The origins of Hodgkin's disease, Eur J Cancer Prev, 4, pp. 379-388, (1995)
[16] Mueller N.E., Hodgkin's disease, Cancer Epidemiology and Prevention, 2nd Edn, (1996)
[17] Mueller N.E., Grufferman S., Epidemiology, Hodgkin's Disease, (1999)
[18] Munoz N., Davidson R.J.L., Witthoff B., Ericsson J.E., De-The G., Infectious mononucleosis and Hodgkin's disease, Int J Cancer, 22, (1978)
[19] Paffenbarger R.S.Jn., Wing A.L., Hyde R.T., Characteristics in youth indicative of adult-onset Hodgkin's disease, J Natl Cancer Inst, 58, (1977)
[20] Pallesen G., Hamilton-Dutoit S.J., Rowe M., Young L.S., Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease, Lancet, 337, pp. 320-322, (1991)

← 1 2 3 →